The National Center for Cancer Care and Research (NCCCR) of the Hamad Medical Corporation has urged cancer patients to take extra precautions to limit their exposure to Covid-19.
“The Department of Radiation Oncology at NCCCR understands and appreciates that patients who are facing cancer treatment, or a cancer diagnosis, during the Covid-19 pandemic may experience significant worry and anxiety regarding their treatment and their timely and safe accessibility to hospitals,” Dr Noora al-Hammadi, chair of the Department said.
“As a department, we would like to reassure our patients that all our radiotherapy-specific cancer services are open as usual. Our doctors are attending their weekly multidisciplinary tumour board meetings to discuss all cases as part of our ongoing efforts to ensure that everyone will be seen and treated without unwanted delays, which could compromise a patient’s treatment outcome,” Dr al-Hammadi added.
She said the Department of Radiation Oncology is committed to treating all radiotherapy patients effectively and in a safe manner.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
MoPH: Total recoveries of Covid-19 rise to 224,384
Tanzanian FM meets Qatari envoy
Voter registration process for Shura Council elections ends
'Covid vaccines in Qatar highly effective against Delta strain'
Qatar’s Hamad International Airport voted the ‘Best Airport in the World’ at the 2021 World Airport Awards
269 persons referred to prosecution for Covid violations
Qatar in UK amber list from Sunday
145 referred to prosecution for Covid violations